Brazil Market

Dr. Reddy’s Secures Brazil Approval for Semaglutide Targeting $244.6M Diabetes Market

Dr. Reddy's Laboratories receives ANVISA approval for generic semaglutide in Brazil, targeting a diabetes market estimated at $244.6 million for the injectable.

Dr Reddys Laboratories · 5 Nov 2026, 9:48 AM IST